Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-28

FDA Approved: GLUCAGON — Original Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Amphastar Pharmaceuticals' original application for a generic glucagon product to treat severe hypoglycemia in patients with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)

Snippet

ORIG AP for GLUCAGON (GLUCAGON)